Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwNHL 2016 | An overview of iwNHL 2016 by Prof. Anas Younes

Anas Younes • 3 Jun 2016
iwNHL 2016
B-Cell Lymphoma Hodgkin Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma T-Cell Lymphoma

Anas Younes, MD of Memorial Sloan Kettering Cancer Center, New York, NY talks about the iwNHL 2016 meeting that will occur between 23–25 September in San Diego, CA. This invitation-only meeting will bring together the top thought leaders in the field of lymphoma. This year the meeting will focus on different types of lymphoma (large cell, mantle cell and T-cell lymphomas), but also areas such as immunotherapy and the updated Response Evaluation Criteria in Solid Tumours (RECIST), that will harmonize lymphoma response criteria using unidimensional measurements.

More from Anas Younes

1:01
Fimepinostat with venetoclax in R/R lymphoma
Anas Younes • 7 Dec 2019
1:27
Atezolizumab plus R-CHOP in DLBCL: encouraging results
Anas Younes • 7 Dec 2019
1:42
Dual inhibition of BCL2 and MCL1 using tumor targeted nanoparticles in lymphoma
Anas Younes • 7 Dec 2019
2:55
Ibrutinib in combination with R-CHOP in DLBCL: does age make a difference?
Anas Younes • 6 Dec 2018

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals